Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

Abstract

Metformin before surgery did not significantly affect Ki-67 overall, but showed significantly different effects according to insulin resistance, particularly in luminal B tumors. Our findings warrant further studies of metformin in breast cancer with careful consideration to the metabolic characteristics of the study population.